"melanoma treatment" trang 2 - tải miễn phí từ tailieunhanh
Báo cáo khoa học:

Báo cáo khoa học: "Diffuse anorectal melanoma; review of the current diagnostic and treatment aspects based on a case report"
4    49    0
Báo cáo khoa học:

Báo cáo khoa học: "The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer"
8    60    0
A formulation study of 5-aminolevulinic encapsulated in DPPC liposomes in melanoma treatment

A formulation study of 5-aminolevulinic encapsulated in DPPC liposomes in melanoma treatment
7    35    0
Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma

Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma
14    84    1
Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma

Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma
7    37    1
PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts

PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts
10    31    1
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: Implications for sensitivity and resistance

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: Implications for sensitivity and resistance
9    32    1
Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: A placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)

Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: A placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)
10    48    1
Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: A systematic literature review and network meta-analysis

Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: A systematic literature review and network meta-analysis
11    55    1
Gene expression and immune infiltration in melanoma patients with different mutation burden

Gene expression and immune infiltration in melanoma patients with different mutation burden
12    25    1
Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma

Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma
11    47    1
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: A single-arm, multicenter, phase II study

Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: A single-arm, multicenter, phase II study
11    4    1
Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment

Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment
9    12    1
Retinoids in skin cancer chemoprophylaxis and treatment

Retinoids in skin cancer chemoprophylaxis and treatment
6    13    1
TREATMENT OF METASTATIC MELANOMA

TREATMENT OF METASTATIC MELANOMA
360    61    0
Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis

Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis
4    40    1
Safety and efficacy of vemurafenib in end stage renal failure

Safety and efficacy of vemurafenib in end stage renal failure
4    34    1
Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: Study protocol of the NIVEC trial

Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: Study protocol of the NIVEC trial
10    3    1
MELANOMA - FROM EARLY DETECTION TO TREATMENT

MELANOMA - FROM EARLY DETECTION TO TREATMENT
730    50    0